Cadila Pharma delivers high-quality, affordable medicines backed by global approvals, robust dossiers, and a strong development pipeline, helping healthcare systems meet real-world needs with confidence.
Registrations across the globe
Products under development across major markets
Global accreditations by leading health authorities
5
continents
85+
countries
8000+
workforce
1400+
products
Driven by continuous development and international accreditations, our generics portfolio is structured to meet evolving healthcare requirements worldwide.
Extensive Global Dossier list across multiple categories
Presence across key therapeutic areas
Advancing research for global patient care
Our dedicated R&D department, comprising 300+ scientists, works round-the-clock to provide solutions for patient cure. The primordial focus is to develop affordable, novel products with the help of cutting-edge technologies. We take immense pride in the strong intellectual capital, experience and expertise of our people.
Our dossier list demonstrates long-standing participation in various key markets, with filings covering multiple strengths and therapeutic needs.
This list of products and reference to any product therein should not be construed and/or constituted transaction where it is not permitted under Patent law of the country and/or is not authorized by other laws and regulations of the country.
Our in-progress formulations cover a diverse set of therapies, with products under development for WHO programs, US and UK requirements, and broader ROW demand.
This list of products and reference to any product therein should not be construed and/or constituted transaction where it is not permitted under Patent law of the country and/or is not authorized by other laws and regulations of the country.
Contact Us
Our Story
Businesses
Therapies
Corporate Identification No : U24231GJ1991PLC015132
©2026 Cadila Pharmaceuticals. All rights reserved
